Clearance Summary
twiist Automated Insulin Delivery (AID) System received FDA 510(k) clearance under submission number K261672, sponsored by Deka Research and Development. The device was reviewed via the Special premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2026-06-17.
- Submission: K261672
- Applicant / Sponsor: Deka Research and Development
- Clearance pathway: Special
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 880.5730
- Decision date: 2026-06-17
Classification & Regulation
This clearance is catalogued under FDA product code QFG and 21 CFR 880.5730, within the Clinical Chemistry review panel as a Class II device.